Abstract Details
|
Anusha Yeshokumar, MD
(Icahn School of Medicine at Mount Sinai)
PRESENTER |
Dr. Yeshokumar has nothing to disclose. |
| Eliza M. Gordon-Lipkin, MD (Kennedy Krieger Institute) | No disclosure on file |
| Ana Arenivas, PhD (Kennedy Krieger Institute) | No disclosure on file |
| Deanna Saylor, MD, MHS (Johns Hopkins Hospital) | Dr. Saylor has received personal compensation in the range of $500-$4,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for 好色先生. The institution of Dr. Saylor has received research support from National Institutes of Health. The institution of Dr. Saylor has received research support from 好色先生. Dr. Saylor has a non-compensated relationship as a Member of multiple committees and task forces focused on improving access to MS medications to people across the world with Multiple Sclerosis International Federation that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the Neurology and COVID19 committee with World Health Organization that is relevant to AAN interests or activities. Dr. Saylor has a non-compensated relationship as a Member of the International Outreach Committee, Junior and Early Career Membership Committee, and 好色先生al Innovation Commitees with American Neurological Association that is relevant to AAN interests or activities. |
| John Probasco, MD, FAAN (The Johns Hopkins Hospital) | Dr. Probasco has received personal compensation in the range of $10,000-$49,999 for serving as an Editor, Associate Editor, or Editorial Advisory Board Member for NEJM Clinician. The institution of Dr. Probasco has received research support from Roche/Genentech. |